Prices delayed by at least 15 minutes | Print
Karolinska Development AB ser.B (KDEV)
Open
1.55 SEK
Previous close
1.55 SEK
Trade high
1.56 SEK
Volume
83,626
Year high
1.95 SEK
Year low
1.41 SEK
Dividend yield
-
Market capitalisation
409.61 mn SEK
P/E ratio
77.50
ISIN
SE0002190926
This share can be held in a Dealing accountISALifetime ISAJISA
Share price
Company profile
Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved, and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; UmecrineCognition; and OssDsign.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.